m+Medelevator.RU
← Поиск публикаций
Frontiers in pediatrics · 2026

The modified woodward procedure via a limited incision for Sprengel deformity: a retrospective study on efficacy and cosmesis.

СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zhang Peng, Su Lianbin, Sun Zijie, Xiao Jun, Zhuge Hengyan, Xu Kefeng, Jin Gengyang, Liu Qi

Аннотация

BACKGROUND: The Woodward procedure is a standard surgical treatment for Sprengel deformity (SD), but its classic execution requires extensive tissue dissection. This study aimed to evaluate the outcomes of a Modified Woodward Procedure via a Limited Incision (MWP-LI), designed to minimize tissue trauma while enhancing functional and cosmetic results.

METHODS: We retrospectively reviewed eight consecutive SD patients (5 Cavendish grade III, 3 grade II) treated with the MWP-LI between January 2022 and December 2023. The key modifications included a short midline incision, creation of a limited trapezius-rhomboid musculofascial flap, dynamic integrated release under continuous scapular traction, and selective scapulothoracic release. Tension-reducing cosmetic closure was employed.

RESULTS: At a mean follow-up of 26.5 months, the mean active shoulder abduction improved significantly by 58.0° (from 96.5° ± 11.8° to 154.5° ± 10.6°, p < 0.001). The mean Cavendish grade improved by 1.8 grades. We recognize that this follow-up duration is insufficient to assess long-term growth-related recurrence; ongoing follow-up is planned. All parents reported high satisfaction with the outcomes. No instances of scapular winging, neurovascular injury, or other major complications were observed.

CONCLUSION: The MWP-LI offers a reliable, less invasive, and cosmetically superior alternative for correcting SD.

LEVEL OF EVIDENCE: Therapeutic Level IV.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты